AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15470337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 10
Study 15470337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11723973 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (completed a toy maze three times a day for 7 days with their left hands)
Number of subjects: 48
Study 11723973 — intervention group
Group type: COMPARATOR
Intervention: Control group (did not train)
Number of subjects: 48
Study 9399010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanepitant 30 mg
Number of subjects: 53
Study 9399010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanepitant 80 mg
Number of subjects: 53
Study 9399010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanepitant 240 mg
Number of subjects: 53
Study 9399010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 7895898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer patients
Number of subjects: 10
Study 7895898 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 10
Study 3300274 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (200 mg tid)
Number of subjects: 126
Study 3300274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 11245765 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric abduction of the arm (two trials per side)
Number of subjects: 24
Study 30628519 — intervention group
Group type: EXPERIMENTAL
Intervention: sequential naïve pinhole bone scan (nPBS)
Number of subjects: 10
Study 30628519 — intervention group
Group type: EXPERIMENTAL
Intervention: sequential gamma correction pinhole bone scan (GCPBS)
Number of subjects: 10
Study 29543506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidcombe Program treatment
Number of subjects: 11
Study 26606167 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model for delayed wound healing using machine learning methods; developed on training data available in the first week of care.
Number of subjects: 59953
Study 26606167 — intervention group
Group type: EXPERIMENTAL
Intervention: Early prediction of delayed healing wounds
Number of subjects: 59953
Study 23780825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 24 weeks
Number of subjects: 66
Study 22858864 — intervention group
Group type: EXPERIMENTAL
Intervention: Social anxiety disorder (SAD) participants
Number of subjects: 0
Study 22858864 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 0
Study 20331676 — intervention group
Group type: EXPERIMENTAL
Intervention: Early educational intervention
Number of subjects: 139
Study 20331676 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 139
Study 20331676 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors
Number of subjects: 139
Study 20331676 — intervention group
Group type: EXPERIMENTAL
Intervention: Home environment
Number of subjects: 139
Study 17683491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosapride citrate 10 mg 1 hour before CE examination
Number of subjects: 60
Study 17683491 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preparation)
Number of subjects: 60
Study 16143696 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (target dose 10 mg QD)
Number of subjects: 1010
Study 16143696 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (target dose 10 mg BID)
Number of subjects: 1010
Study 12374439 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who imagined being with a group at Time 1
Number of subjects: 0
Study 12374439 — intervention group
Group type: COMPARATOR
Intervention: Participants who imagined being alone with one other person at Time 1
Number of subjects: 0
Study 12374439 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who imagined the presence of others
Number of subjects: 0
Study 10407709 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letter + phone call (group 3)
Number of subjects: 298
Study 10407709 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letter (group 2)
Number of subjects: 298
Study 10407709 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group 1)
Number of subjects: 298
Study 8624229 — intervention group
Group type: EXPERIMENTAL
Intervention: Tartar‐Control Crest (3.3% pyrophosphate)
Number of subjects: 163
Study 8624229 — intervention group
Group type: COMPARATOR
Intervention: Regular Crest (without pyrophosphate)
Number of subjects: 163
Study 2208231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 60 mg per day
Number of subjects: 25
Study 2208231 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem, 270 mg per day
Number of subjects: 25
Study 2208231 — intervention group
Group type: COMPARATOR
Intervention: Combination of 30 mg nifedipine per day with 180 mg diltiazem per day
Number of subjects: 25
Study 2208231 — intervention group
Group type: COMPARATOR
Intervention: Combination of 60 mg nifedipine per day with 270 mg diltiazem per day
Number of subjects: 25
Study 2208231 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 25
Study 7191306 — intervention group
Group type: EXPERIMENTAL
Intervention: Acemetacin (t.i.d. for 10 days)
Number of subjects: 0
Study 7191306 — intervention group
Group type: COMPARATOR
Intervention: Indometacin (equimolar doses, t.i.d. for 10 days)
Number of subjects: 0
Study 7191306 — intervention group
Group type: EXPERIMENTAL
Intervention: Acemetacin (single dose)
Number of subjects: 0
Study 7191306 — intervention group
Group type: COMPARATOR
Intervention: Indometacin (single dose)
Number of subjects: 0
Study 7191306 — intervention group
Group type: EXPERIMENTAL
Intervention: Acemetacin and Indometacin (after multiple application)
Number of subjects: 0
Study 7191306 — intervention group
Group type: EXPERIMENTAL
Intervention: Acemetacin (after multiple application)
Number of subjects: 0
Study 7191306 — intervention group
Group type: COMPARATOR
Intervention: Indometacin (after multiple application)
Number of subjects: 0
Study 31088438 — intervention group
Group type: EXPERIMENTAL
Intervention: Food4toddlers eHealth intervention (6-month duration)
Number of subjects: 404
Study 31088438 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 404
Study 28104418 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahmed implant
Number of subjects: 514
Study 28104418 — intervention group
Group type: COMPARATOR
Intervention: Baerveldt implant
Number of subjects: 514
Study 25835440 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 1503
Study 25835440 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 1503
Study 25835440 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 1503
Study 25835440 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with events
Number of subjects: 1503
Study 23683451 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend monitor
Number of subjects: 80
Study 23683451 — intervention group
Group type: COMPARATOR
Intervention: Standard group (control)
Number of subjects: 80
Study 22843282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafamidis 20 mg QD
Number of subjects: 125
Study 22843282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 19423108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10-20mg daily)
Number of subjects: 7196
Study 19423108 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus pravastatin
Number of subjects: 7196
Study 19423108 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 7196
Study 17332205 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting-skills training plus intensive lifestyle education
Number of subjects: 111
Study 17332205 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting-skills training alone
Number of subjects: 111
Study 17332205 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 111
Study 15683158 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (midwife visits during pregnancy and one after delivery)
Number of subjects: 149
Study 15683158 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard written information about health risks)
Number of subjects: 149
Study 15683158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 149
Study 15683158 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study 15683158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (after controlling for socio-demographic characteristics)
Number of subjects: 149
Study 15683158 — intervention group
Group type: COMPARATOR
Intervention: Control group (after controlling for socio-demographic characteristics)
Number of subjects: 149
Study 11161243 — intervention group
Group type: EXPERIMENTAL
Intervention: Locus-specific amplification
Number of subjects: 59
Study 11161243 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-specific amplification
Number of subjects: 59
Study 11161243 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequence-specific amplification
Number of subjects: 59
Study 11161243 — intervention group
Group type: EXPERIMENTAL
Intervention: Locus-specific amplification (clinical samples)
Number of subjects: 59
Study 9700992 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 990 mg/day plus dipyridamole 225 mg/day
Number of subjects: 1306
Study 9700992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study 7978695 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg folic acid weekly
Number of subjects: 79
Study 7978695 — intervention group
Group type: EXPERIMENTAL
Intervention: 27.5 mg folic acid weekly
Number of subjects: 79
Study 7978695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 7978695 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (both doses)
Number of subjects: 79
Study 2691812 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and exercise (FE), N = 7, 50 ml of oil daily and 3 d.wk‐1 of aerobic exercise
Number of subjects: 34
Study 2691812 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (F), N = 7, 50 ml of oil daily
Number of subjects: 34
Study 2691812 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil (CN), N = 10, 50 ml of oil daily
Number of subjects: 34
Study 2691812 — intervention group
Group type: COMPARATOR
Intervention: Control (C), N = 10
Number of subjects: 34
Study 29948869 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen iv (n = 63)
Number of subjects: 127
Study 28017186 — intervention group
Group type: EXPERIMENTAL
Intervention: 25mg CAR
Number of subjects: 106
Study 28017186 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg CAR
Number of subjects: 106
Study 28017186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 28017186 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 106
Study 26636279 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Hz WBV training
Number of subjects: 22
Study 26636279 — intervention group
Group type: COMPARATOR
Intervention: 50 Hz WBV training
Number of subjects: 22
Study 24565346 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia and femoral nerve block (FNB)
Number of subjects: 53
Study 24565346 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (GA)
Number of subjects: 53
Study 21676083 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol tablets (25 µg, 4-hourly, max 5 doses)
Number of subjects: 212
Study 21676083 — intervention group
Group type: COMPARATOR
Intervention: Vaginal dinoprostone (PGE2) gel (0.5 mg, 6-hourly, max 2 doses)
Number of subjects: 212
Study 18458358 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr) loading (5 g dicreatine citrate plus 10 g of flavored fructose powder per packet, 20 g/d for 5 days)
Number of subjects: 16
Study 18458358 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl; 10 g of flavored fructose powder per packet)
Number of subjects: 16
Study 16801033 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal positive pressure ventilation (NNPPV) for 6 months
Number of subjects: 29
Study 16801033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 29
Study 12710224 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated olfactory ability
Number of subjects: 203
Study 12710224 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients
Number of subjects: 203
Study 12710224 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 203
Study 11063477 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk
Number of subjects: 0
Study 11063477 — intervention group
Group type: COMPARATOR
Intervention: Formula (low cholesterol)
Number of subjects: 0
Study 11063477 — intervention group
Group type: COMPARATOR
Intervention: Formula high in linoleate
Number of subjects: 0
Study 11063477 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet providing <22% of energy from fat and low in animal fats
Number of subjects: 0
Study 11063477 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake
Number of subjects: 0
Study 11063477 — intervention group
Group type: EXPERIMENTAL
Intervention: Wasting (percentage weight-for-height <2 SDs)
Number of subjects: 0
Study 9138958 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler assessment
Number of subjects: 790
Study 8093548 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-LA
Number of subjects: 6
Study 8093548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3512226 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonretard isosorbide dinitrate, 20 and 40 mg six times daily
Number of subjects: 10
Study 3512226 — intervention group
Group type: COMPARATOR
Intervention: Crossover double-blind randomized study
Number of subjects: 10
Study 31746542 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% tetracaine hydrochloride injection pure solution aerosol inhalation combined with oral 5 mL of dyclonine hydrochloride mucilage
Number of subjects: 523
Study 31746542 — intervention group
Group type: COMPARATOR
Intervention: Diluted tetracaine hydrochloride injection (3 mL of 1% tetracaine hydrochloride injection + 3 mL of sterile water for injection) aerosol inhalation combined with oral 5 mL of dyclonine hydrochloride mucilage
Number of subjects: 523
Study 31107843 — intervention group
Group type: EXPERIMENTAL
Intervention: FocusSpecs adjustable spectacles
Number of subjects: 86
Study 28643436 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional awareness and expression training (EAET)
Number of subjects: 106
Study 28643436 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 106
Study 28643436 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 106
Study 26160211 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable Velcro compression devices (AVCDs)
Number of subjects: 36
Study 26160211 — intervention group
Group type: COMPARATOR
Intervention: Inelastic bandages (IBs)
Number of subjects: 36
Study 26160211 — intervention group
Group type: EXPERIMENTAL
Intervention: Both compression devices
Number of subjects: 36
Study 23388468 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of snack-eating behavior
Number of subjects: 0
Study 23388468 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of alcohol-drinking behavior
Number of subjects: 0
Study 22098180 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Nutrition Intervention (B-NICE)
Number of subjects: 0
Study 19726771 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum (0.58 mg per injection)
Number of subjects: 308
Study 19726771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 19726771 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum
Number of subjects: 308
Study 18162014 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex monotherapy (target dose level, 70‐90 ng/dL)
Number of subjects: 18
Study 18162014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 14609035 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg bid for 4 weeks
Number of subjects: 31
Study 14609035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 10789569 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified hemofiltration
Number of subjects: 40
Study 10789569 — intervention group
Group type: COMPARATOR
Intervention: Control (standard technique)
Number of subjects: 40
Study 8851312 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol hydrobromide (600 micrograms) during 3-minute UNDW inhalation
Number of subjects: 17
Study 8851312 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol hydrobromide (400 micrograms) during 1-minute UNDW inhalation
Number of subjects: 17
Study 8851312 — intervention group
Group type: COMPARATOR
Intervention: Inhaled oxitropium bromide (300 micrograms) during 3-minute UNDW inhalation
Number of subjects: 17
Study 1505329 — intervention group
Group type: EXPERIMENTAL
Intervention: Modem group
Number of subjects: 42
Study 1505329 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 6418654 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced AA solution with 10% branched chain amino acids (BCAA)
Number of subjects: 3
Study 6418654 — intervention group
Group type: COMPARATOR
Intervention: AA solution with 60% BCAA
Number of subjects: 3
Study 6418654 — intervention group
Group type: COMPARATOR
Intervention: AA solution with 67% alanine
Number of subjects: 3
Study 2412070 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (selective S2-serotonergic receptor antagonist)
Number of subjects: 0
Study 2412070 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0
Study 2412070 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapies
Number of subjects: 0
Study 30353303 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term oxygen therapy
Number of subjects: 331
Study 27686343 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitric oxide (20 ppm)
Number of subjects: 198
Study 24527467 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 µg dexmedetomidine added to 3 mL (15 mg) hyperbaric bupivacaine
Number of subjects: 60
Study 24527467 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 µg dexmedetomidine added to 3 mL (15 mg) hyperbaric bupivacaine
Number of subjects: 60
Study 24527467 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL saline added to 3 mL (15 mg) hyperbaric bupivacaine
Number of subjects: 60
Study 21937481 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (LAmB) plus deferasirox (20 mg/kg/day for 14 days)
Number of subjects: 20
Study 21937481 — intervention group
Group type: COMPARATOR
Intervention: LAmB plus placebo
Number of subjects: 20
Study 20826626 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg dihydrocapsiate/d
Number of subjects: 78
Study 20826626 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mg dihydrocapsiate/d
Number of subjects: 78
Study 20826626 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data from both dihydrocapsiate groups
Number of subjects: 78
Study 20826626 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg dihydrocapsiate/d)
Number of subjects: 78
Study 18379965 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodality therapy (including TUR, radiation, and chemotherapy)
Number of subjects: 0
Study 18379965 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiochemotherapy
Number of subjects: 0
Study 18379965 — intervention group
Group type: COMPARATOR
Intervention: Radical cystectomy
Number of subjects: 0
Study 18379965 — intervention group
Group type: COMPARATOR
Intervention: Organ-preserving approach (including TUR and intravesical therapy)
Number of subjects: 0
Study 15941630 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/NETA (2mg of 17beta‐oestradiol combined with 1mg of norethisterone acetate)
Number of subjects: 75
Study 15941630 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5mg/day)
Number of subjects: 75
Study 15941630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 75
Study 12926839 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA)
Number of subjects: 540
Study 12926839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 10947687 — intervention group
Group type: EXPERIMENTAL
Intervention: Single injection peribulbar block
Number of subjects: 51
Study 8818756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 165
Study 8818756 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 165
Study 8818756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 1428467 — intervention group
Group type: EXPERIMENTAL
Intervention: Active agents
Number of subjects: 0
Study 1428467 — intervention group
Group type: COMPARATOR
Intervention: Active corticosteroids
Number of subjects: 0
Study 6230034 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (40 micrograms) and theophylline (oxtriphylline 400 mg)
Number of subjects: 24
Study 6230034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31205487 — intervention group
Group type: EXPERIMENTAL
Intervention: SPMC oral solution
Number of subjects: 901
Study 31205487 — intervention group
Group type: COMPARATOR
Intervention: P/MC powder
Number of subjects: 901
Study 30219444 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound-bed music intervention
Number of subjects: 48
Study 30219444 — intervention group
Group type: COMPARATOR
Intervention: Control condition (resting time)
Number of subjects: 48
Study 26540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-Focused Therapy (SFT)
Number of subjects: 326
Study 26540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (SPP)
Number of subjects: 326
Study 26540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-Term Psychodynamic Psychotherapy (LPP)
Number of subjects: 326